US Patent

US10022510 — Dose counters for inhalers, inhalers and methods of assembly thereof

Formulation · Assigned to Teva Pharmaceuticals Ireland · Expires 2031-05-18 · 5y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a tape system for a dose counter in inhalers, including features for tracking dosages and priming.

USPTO Abstract

A tape system for a dose counter for an inhaler, the tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the tape, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and one end of the tape.

Drugs covered by this patent

Patent Metadata

Patent number
US10022510
Jurisdiction
US
Classification
Formulation
Expires
2031-05-18
Drug substance claim
No
Drug product claim
Yes
Assignee
Teva Pharmaceuticals Ireland
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.